Print Page     Close Window     

SEC Filings

424B3
BIOTIME INC filed this Form 424B3 on 02/04/2019
Entire Document
 
 

 

Precedent biotechnology transactions:

 

Date Closed   Target   Buyer
01/31/2018   Repros Therapeutics Inc. (NasdaqCM:RPRX)   Allergan Sales, LLC
12/11/2017   Ocera Therapeutics, Inc. (NASDAQ:OCRX)   MAK LLC
11/07/2017   Dimension Therapeutics, Inc. (NASDAQ:DMTX)   Ultragenyx Pharmaceutical Inc. (NasdaqGS:RARE)
06/16/2017   GenVec, Inc. (NasdaqCM:GNVC)   Intrexon Corporation (NasdaqGS:XON)
11/29/2016   Aegerion Pharmaceuticals, Inc. (NasdaqGS:AEGR)   Novelion Therapeutics Inc. (NasdaqGS:NVLN)
06/29/2016   Nanosphere, Inc. (NASDAQ:NSPH)   Luminex Corporation (NasdaqGS:LMNX)
05/06/2016   VBI Vaccines Inc (NasdaqCM:VBIV)   SciVac Therapeutics Inc. (TSX:VAC)
02/09/2016   Ocata Therapeutics, Inc. (NasdaqGM:OCAT)   Astellas Pharma Inc. (TSE: 4503)

 

Precedent healthcare transactions:

 

Date Closed   Target   Buyer
10/22/2018   Invuity, Inc. (NASDAQ: IVTY)   Stryker Corporation (NYSE:SYK)
08/30/2018   SteadyMed Ltd. (NASDAQ: STDY)   United Therapeutics Corporation (NasdaqGS:UTHR)
08/13/2018   Juniper Pharmaceuticals, Inc. (NASDAQ: JNPR)   Catalent Pharma Solutions, Inc.
04/20/2018   Cogentix Medical, Inc. (NasdaqCM:CGNT)   LM US Parent, Inc.
01/31/2018   Repros Therapeutics Inc. (NasdaqCM:RPRX)   Allergan Sales, LLC
12/27/2017   MGC Diagnostics Corporation (NasdaqCM:MGCD)   Altus Capital Partners
12/11/2017   Ocera Therapeutics, Inc. (NASDAQ:OCRX)   MAK LLC
11/14/2017   CombiMatrix Corporation (NasdaqCM:CBMX)   Invitae Corporation (NYSE:NVTA)
11/07/2017   Dimension Therapeutics, Inc. (NASDAQ:DMTX)   Ultragenyx Pharmaceutical Inc. (NasdaqGS:RARE)
07/31/2017   Nexvet Biopharma Public Ltd Company (NasdaqGM:NVET)   Zoetis Inc. (NYSE:ZTS)
07/24/2017   Innocoll Holdings plc (NasdaqGM:INNL)   Gurnet Point Capital Limited
07/17/2017   Syneron Medical Ltd. (NasdaqGS:ELOS)   Apax Partners (Israel) Ltd
06/16/2017   Span-America Medical Systems, Inc. (NasdaqGM:SPAN)   Savaria Corporation (TSX:SIS)
06/16/2017   GenVec, Inc. (NasdaqCM:GNVC)   Intrexon Corporation (NasdaqGS:XON)
02/22/2017   Derma Sciences, Inc. (NasdaqCM:DSCI)   Integra LifeSciences Holdings Corp. (NasdaqGS:IART)
11/29/2016   Aegerion Pharmaceuticals, Inc. (NasdaqGS:AEGR)   Novelion Therapeutics Inc. (NasdaqGS:NVLN)
11/21/2016   EndoChoice Holdings, Inc. (NYSE:GI)   Boston Scientific Corporation (NYSE:BSX)
09/30/2016   USMD Holdings, Inc. (NasdaqCM:USMD)   WellMed Medical Management Inc.
09/07/2016   Sequenom Inc. (NasdaqGS:SQNM)   Laboratory Corporation of America Holdings (NYSE:LH)
07/27/2016   Hansen Medical, Inc. (NasdaqGM:HNSN)   Auris Health, Inc.
07/01/2016   Symmetry Surgical Inc. (NasdaqGM:SSRG)   RoundTable Healthcare Management, LLC
06/29/2016   Nanosphere, Inc. (NASDAQ:NSPH)   Luminex Corporation (NasdaqGS:LMNX)
06/21/2016   Alexza Pharmaceuticals Inc. (NasdaqCM:ALXA)   Grupo Ferrer Internacional, S.A.
05/09/2016   VirtualScopics Inc. (NasdaqCM:VSCP)   BioTelemetry, Inc. (NasdaqGS:BEAT)
05/06/2016   VBI Vaccines Inc (NasdaqCM:VBIV)   SciVac Therapeutics Inc. (TSX:VAC)
02/09/2016   Ocata Therapeutics, Inc. (NasdaqGM:OCAT)   Astellas Pharma Inc. (TSE: 4503)
02/03/2016   TriVascular Technologies, Inc. (Nasdaq:TRIV)   Endologix, Inc. (Nasdaq:ELGX)
12/04/2015   DARA BioSciences, Inc. (NASDAQ: DARA)   Midatech Pharma PLC (AIM: MTPH)

 

62

© Copyright BioTime, Inc.